Turning Point Benefit Group’s ACM Research ACMR Stock Holding History

Turning Point Benefit Group’s Portfolio ACMR Stock Details ACMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9	Closed	-$394	–	848
2025 Q3	$394	Buy	+9	New	+$267	﹤0.01%	541

Other funds holding ACMR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Triata Capital Hong Kong $588M AUM 8.92% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Turning Point Benefit Group's ACMR Position: Q4 2025 in Review

Turning Point Benefit Group sold out of ACM Research (ACMR) in Q4 2025, closing a stake of 9 shares — an estimated $394 sold.

Turning Point Benefit Group first reported a position in ACMR in Q3 2025 and held it in 1 quarter. The position peaked at $394 in Q3 2025. 278 funds tracked by Wall St. Rank hold ACMR as of Q4 2025.

Turning Point Benefit Group reported no remaining ACM Research position as of Q4 2025 after selling out during the quarter.
Turning Point Benefit Group sold 9 ACM Research shares in Q4 2025, an estimated $394.
Turning Point Benefit Group first reported a position in ACM Research in Q3 2025 and held it in 1 quarter.
Turning Point Benefit Group's ACM Research position peaked at $394 in Q3 2025.
278 funds tracked by Wall St. Rank held ACM Research as of Q4 2025.

Based on Turning Point Benefit Group's 13F filing for Q4 2025, filed 30 Jan 2026.